National Institutes of Health researchers have uncovered a key factor in understanding the elevated cancer risk associated with gene therapy.
Mutated ATRX gene linked to brain tumors; potential biomarker for rare adrenal tumors too
1/23/2015
A somatic mutation in the ATRX gene has recently been shown as a potential molecular marker for aggressive brain tumors, such as gliomas, neuroblastomas and pancreatic neuroendocrine tumors.
Better outlook for patients with CLL - four new treatments transform care
1/23/2015
The American Society of Clinical Oncology (ASCO) for the first time announced its cancer Advance of the Year: the transformation of treatment for the most common form of adult leukemia.
Hardening cells to prevent cancer metastasis
1/23/2015
Existing cancer therapies are geared toward massacring tumor cells, but Johns Hopkins researchers propose a different strategy: subtly hardening cancer cells to prevent them from invading new areas...
System invented to improve effectiveness of cancer surgery
1/23/2015
With the goal of making it easier for surgeons to detect malignant tissue during surgery and hopefully reduce the rate of cancer recurrence, scientists have invented a new imaging system that causes...
In women with Alzheimer's disease, prostate cancer drug slows memory loss
1/23/2015
Women with Alzheimer's disease showed stable cognition for a year when a drug that is more commonly used to treat advanced prostate cancer was added to their drug regimen, according to a new study...
A groundbreaking TGen-led discovery of the likely genetic cause of an ovarian cancer that strikes young women and girls is featured in the annual report of the American Society of Cancer Oncology...
Scientists investigate sound waves for burning away cancer pain
1/22/2015
Used primarily in medicine as a way to image the body, ultrasound at high-intensity may also provide an exciting new treatment for cancer pain, according to early trial results.
VolitionRX begins first ovarian cancer detection study to evaluate blood-based test
1/22/2015
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, has announced it has signed an agreement to...
Long-term use of hormonal contraceptives is associated with an increased risk of brain tumours
1/22/2015
Taking a hormonal contraceptive for at least five years is associated with a possible increase in a young woman's risk of developing a rare tumour, glioma of the brain.